Cicekli, M. N. Et Al. 2022. GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.42, no.5 , 486-494.

Cicekli, M. N., Tiryaki, E. S., ALTUN, A., & Gunaydin, C., (2022). GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.42, no.5, 486-494.

Cicekli, Mustafa Et Al. "GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway," JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.42, no.5, 486-494, 2022

Cicekli, Mustafa N. Et Al. "GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway." JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.42, no.5, pp.486-494, 2022

Cicekli, M. N. Et Al. (2022) . "GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway." JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.42, no.5, pp.486-494.

@article{article, author={Mustafa Nusret Cicekli Et Al. }, title={GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3 beta pathway}, journal={JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION}, year=2022, pages={486-494} }